| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |